Drug ID: | NPD3015 |
Drug Name: | FK-613 |
Molecular Formula: | C18H22N4O2S2 |
Canonical SMILES: | CS(=O)(=O)Nc1scc(n1)CN1CCC(CC1)c1c[nH]c2c1cccc2 |
Standard InCHI: | InChI=1S/C18H22N4O2S2/c1-26(23,24)21-18-20-14(12-25-18)11-22-8-6-13(7-9-22)16-10-19-17-5-3-2-4-15(16)17/h2-5,10,12-13,19H,6-9,11H2,1H3,(H,20,21) |
Standard InCHIKey: | XLFASBVDVQTBES-UHFFFAOYSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB014482 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 390.12 |
ALogP | -1.4981 |
MLogP | 2.56 |
XLogP | 2.771 |
HDA | 6 |
HBD | 2 |
Rotatable Bonds | 6 |
TPSA | 114.71 |
RO5 Violation | 0 |